Roche

Swiss stocks slip as U.S. futures fall; Roche, Novartis rise; ABB leads declines

Swiss Market Index dips 0.13% as global equities drift lower on rising yields and Middle East tensions. Roche and Novartis gain, while cyclical stocks like ABB and construction firms retreat.

Markets Desk · 19 Aug 2026

EquitiesArticle

Swiss drugmakers limit reimbursement requests amid U.S. pricing pressures

Pharmaceutical firms in Switzerland are reducing applications for state reimbursement as U.S. drug pricing policies raise cost concerns.

Markets Desk · 16 Aug 2026